BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 6609265)

  • 1. Increased adenosine deaminase (ADA) activity and a shift from ADA-dependent to ADA-independent phases during T-cell activation: a paradox.
    Veit BC; Fishman M; Look T
    J Natl Cancer Inst; 1984 May; 72(5):1151-9. PubMed ID: 6609265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2'Deoxycoformycin and deoxyadenosine affect IL 2 production and IL 2 receptor expression of human T cells.
    Ruers TJ; Buurman WA; van der Linden CJ
    J Immunol; 1987 Jan; 138(1):116-22. PubMed ID: 3097141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
    Webster AD; Ip H; Pereira S
    Clin Exp Immunol; 1982 Dec; 50(3):587-95. PubMed ID: 6299634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of adenosine deaminase deficiency on thymocyte metabolism.
    Thuillier L; Garreau F; Cartier PH
    Eur J Immunol; 1981 Oct; 11(10):788-94. PubMed ID: 6975717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of adenosine deaminase activity in cultured murine cytotoxic T lymphocytes.
    Minkowski MD; Castellazzi M; Buttin G
    J Immunol; 1984 Jul; 133(1):52-8. PubMed ID: 6609994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis.
    Carson DA; Seegmiller JE
    J Clin Invest; 1976 Feb; 57(2):274-82. PubMed ID: 176177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule.
    Martín M; Huguet J; Centelles JJ; Franco R
    J Immunol; 1995 Nov; 155(10):4630-43. PubMed ID: 7594462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azacytidine-induced reactivation of adenosine deaminase in a murine cytotoxic T cell line.
    Castellazzi M; Vielh P; Longacre S
    Eur J Immunol; 1986 Sep; 16(9):1081-6. PubMed ID: 2428625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between adenosine deaminase and a human thymus leukemia antigen isolated from MOLT 4 cells.
    Dowell BL; Segars JH; Metzgar RS
    Cancer Res; 1981 Jan; 41(1):343-5. PubMed ID: 7192600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of adenosine deaminase in lymphocyte proliferation.
    Hovi T; Smyth JF; Allison AC; Williams SC
    Clin Exp Immunol; 1976 Mar; 23(3):395-403. PubMed ID: 133008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An approach to a selection system for adenosine-deaminase-positive (ADA+) cells and detection of rat ADA+ "revertants".
    Hirschhorn R; Ellenbogen A; Martiniuk F
    J Cell Physiol; 1985 May; 123(2):277-82. PubMed ID: 3872305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of three T-lymphoid cell lines with distinct sensitivities to deoxyadenosine plus deoxycoformycin.
    Duan DS; Smith W; Sadée W; Cowan MJ
    Thymus; 1992 Feb; 19(1):1-11. PubMed ID: 1373528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes.
    Ratech H; Kim J; Asofsky R; Thorbecke GJ; Hirschhorn R
    J Immunol; 1984 Jun; 132(6):3077-84. PubMed ID: 6202772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the relationship between adenosine deaminase and immune function.
    Burridge PW; Paetkau V; Henderson JF
    J Immunol; 1977 Aug; 119(2):675-8. PubMed ID: 301901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic changes and immunohistochemical localization of adenosine deaminase in tissues of rats given injections of 2'-deoxycoformycin.
    Checkik BE; Perets A; SenGupta S; Fernandes B
    J Natl Cancer Inst; 1983 Nov; 71(5):999-1010. PubMed ID: 6358608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The distribution of adenosine deaminase among lymphocyte populations in the rat.
    Barton R; Martiniuk F; Hirschhorn R; Goldschneider I
    J Immunol; 1979 Jan; 122(1):216-20. PubMed ID: 310828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deoxyadenosine (AdR) inhibition of newly activated lymphocytes: blockade at the G0-G1 interface.
    Redelman D; Bluestein HG; Cohen AH; Depper JM; Wormsley S
    J Immunol; 1984 Apr; 132(4):2030-8. PubMed ID: 6421932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response.
    Dong RP; Kameoka J; Hegen M; Tanaka T; Xu Y; Schlossman SF; Morimoto C
    J Immunol; 1996 Feb; 156(4):1349-55. PubMed ID: 8568233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine metabolism in phytohemagglutinin-stimulated human lymphocytes.
    Snyder FF; Mendelsohn J; Seegmiller JE
    J Clin Invest; 1976 Sep; 58(3):654-66. PubMed ID: 956393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine-resistant Chinese hamster fibroblast variants with hyperactive adenosine-deaminase: an analysis of the protection against exogenous adenosine afforded by increased activity of the deamination pathway.
    Fernandez-Mejia C; Debatisse M; Buttin G
    J Cell Physiol; 1984 Sep; 120(3):321-8. PubMed ID: 6205001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.